Pulmonary renal syndrome in a child with coexistence of anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane disease: Case report and literature review

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Bogdanović, Radovan ^a,b   Minić, Predrag ^a,b   Marković Lipkovski, Jasmina ^a   Stajić, Nataša ^a,b   Savić, Nataša ^a,b   Rodić, Milan ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute of Mother and Child Healthcare of Serbia Dr Vukan upi   (Serbia)

Author keywords

Anti glomerular basement membrane disease; Anti myeloperoxidase anti neutrophil cytoplasmic antibodies; Children; Pulmonary renal syndrome

Indexed keywords

CYCLOPHOSPHAMIDE; HEMOGLOBIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADOLESCENT; ANEMIA; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; FATIGUE; FEMALE; FEVER; FIBEROPTIC BRONCHOSCOPY; FOLLOW UP; GLOMERULONEPHRITIS; HEMOGLOBIN BLOOD LEVEL; HEMOPTYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION TEST; LUNG DISEASE; LUNG FUNCTION TEST; LUNG HEMORRHAGE; MALAISE; MALE; PRESCHOOL CHILD; PROTEINURIA; PULMONARY RENAL SYNDROME; REVIEW; SCHOOL CHILD; THORAX RADIOGRAPHY; URINALYSIS;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHILD; FEMALE; GLOMERULONEPHRITIS; HEMORRHAGE; HUMANS; LUNG DISEASES;

EID: 84875133377     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-66     Document Type: Review

References (44)

1. Pulmonary renal syndrome: A 4-year, single-center experience. Gallagher H, Kwan JTC, Jayne DRW, Am J Kidney Dis 2002 39 42 47 10.1053/ajkd.2002.29876 11774100
2. Pulmonary renal vasculitis syndromes. Lee RW, D'Cruz DP, Autoimmun Rev 2010 9 657 660 10.1016/j.autrev.2010.05.012 20472100
3. Pulmonary renal syndrome in childhood: a report of twenty-one cases and a review of the literature. Von Vigier RO, Trummler SA, Laux-End R, Sauvain MJ, Truttmann AC, Bianchetti MG, Pediatr Pulmonol 2000 29 382 388 10.1002/(SICI)1099-0496(200005)29:5<382::AID-PPUL7>3.0.CO;2-D 10790250
4. Small-vessel vasculitis. Jennette JC, Falk RJ, N Engl J Med 1997 337 1512 1523 10.1056/NEJM199711203372106 9366584
5. Anti-glomerular basement membrane disease. Kluth DC, Rees AJ, J Am Soc Nephrol 1999 10 2446 2453 10541306
6. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Jayne DRW, Marshall PD, Jones SJ, Lockwood CM, Kidney Int 1990 37 965 970 10.1038/ki.1990.72 2179617
7. Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis. Bosch X, Mirapeix E, Font J, Cervera R, Ingelmo M, Khamashta MA, Revert L, Hughes GR, Urbano-Marquez A, Am J Kidney Dis 1992 20 231 239 1325737
8. Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. Weber MFA, Nadrossy K, Pullig O, Koderisch J, Netzer K, J Am Soc Nephrol 1992 2 1227 1234 1317224
9. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Short AK, Esnault VL, Lockwood CM, Am J Kidney Dis 1995 26 439 445 10.1016/0272-6386(95)90489-1 7544065
10. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD, Kidney Int 2004 66 2535 2540
11. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentis gomerulonephritis. Rutgers A, Slot M, Passen PV, Vriesman PVB, Heeninga P, Tervaert JWC, Am J Kidney Dis 2005 46 253 262 10.1053/j.ajkd.2005.05.003 16112043
12. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane. Lindič J, Vizjak A, Ferluga D, Kovač D, Aleš A, Kveder R, Ponikvar R, Bren A, Ther Apher Dial 2009 13 278 281 10.1111/j.1744-9987.2009.00724.x 19695059
13. Incidence and features of dual anti-GBM-positive and ANCA-positive patients. Zoysa J, Taylor D, Thein H, Yehia M, Nephrology 2011 16 725 729 10.1111/j.1440-1797.2011.01484.x 21649794
14. Case 52-1993: A 17-year-old girl with massive hemoptysis and acute oliguric renal failure. Fanburg BL, Niles JL, Mark EJ, N Engl J Med 1993 329 2019 2026 10.1056/NEJM199312303292708 8247078
15. A 12-year-old girl with pulmonary hemorrhage, skin lesions, and hematuria. Paueksakon P, Hynley TE, Lee SM, Fogo AB, Am J Kidney Dis 1999 33 404 409 10.1016/S0272-6386(99)70321-5 10023658
16. Anti-GBM and anti-MPO antibodies coexist in a case of pulmonary renal syndrome. Hijosa MM, Espinosa RL, Fernandez C, Picazo Garcia ML, Pascual Salcedo D, Navarro Torres M, Pediatr Nephrol 2005 20 807 810 10.1007/s00467-004-1762-z 15782311
17. Anti-GBM antibodies co-exist with MPO-ANCA in a 4-year-old girl with acute renal failure. Naidoo S, Waller S, Pediatr Nephrol 2009 24 215 216 10.1007/s00467-008-0928-5 18607637
18. A 25-year experience with pediatric anti-glomerular basement membrane disease. Williamson SR, Phillips CL, Andreoli SP, Nailescu C, Pediatr Nephrol 2011 26 85 91 10.1007/s00467-010-1663-2 20963446
19. Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Lionaki S, Jennette JC, Falk RJ, Semin Immunopathol 2007 29 459 474 10.1007/s00281-007- 0093-0 17943286
20. Crescentic glomerulonephritis: an update on pauci-immune and anti-GBM diseases. Kambham N, Adv Anat Pathol 2012 19 111 124 10.1097/PAP. 0b013e318248b7a1 22313839
21. Vasculitis. Rees L, Webb NJA, Brogan PA, Paediatric Nephrology Oxford: OUP, Rees L, Webb NJA, Brogan PA, 2007 297 316
22. Valentini RP, Pediatric anti-GBM disease (Good pasture Syndrome) http://emedicine.medscape.com/article/1001872-overview
23. Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis. Pedchenko V, Vanacore R, Hudson B, Curr Opin Nephrol Hypertens 2011 20 290 296 10.1097/MNH.0b013e328344ff20 21378566
24. Pathogenesis of ANCA-associated vasculitides. Kallenberg CG, Ann Rheum Dis 2011 70 159 163
25. Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Jennette JC, Falk RJ, Gasim AH, Curr Opin Nephrol Hypertens 2011 20 263 270 10.1097/MNH.0b013e3283456731 21422922
26. Comparison of anti-GBM antibodies in sera with or without ANCA. Hellmark T, Niles JL, Collins B, Mccluskey RT, Brunmark C, J Am Soc Nephrol 1997 8 376 385 9071706
27. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with Goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao M, Wang H, J Am Soc Nephrol 2007 18 1338 1343 10.1681/ASN.2006111210 17329569
28. Alport's syndrome, Goodpasture's syndrome, and type IV colagen. Hudson BG, Tryggvason K, Sudaramoorthy M, Neilson EG, N Engl J Med 2003 348 2543 2556 10.1056/NEJMra022296 12815141
29. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Serratrice J, Chiche L, Dussol B, Granel B, Daniel L, Jego-Desplat S, Disdier P, Swiader L, Berland Y, Weiller PJ, Am J Kidney Dis 2004 43 26 e30 10.1053/j.ajkd.2003.11.019 14981638
30. Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. Olson SW, Arbogast CB, Baker TP, Owhalimpur D, Oliver DK, Abbott KC, Yuan CM, J Am Soc Nephrol 2011 22 1946 1952 10.1681/ASN. 2010090928 21868497
31. Sequential development of pulmonary hemorrhage with MPO-ANCA complicating anti-glomerular basment membrane antibody-mediated glomerulonephritis. Peces R, Rodrigues M, Pobes A, Seco M, Am J Kidney Dis 2000 35 954 957 10.1016/S0272-6386(00)70269-1 10793033
32. Sequential development of pulmonary renal syndrome asociated with c-ANCA 3 years after development of anti-GBM glomerulonephritis. Desai A, Goldschmidt RA, Kim GC, Nephrol Dial Transplant 2007 22 926 929 10.1093/ndt/gfl751 17210587
33. Late emergence of systemic vasculitis with anti-neutrophil cytoplasmic antibodies in a dialyzed patient with anti-glomerular basement glomerulonephritis. Vanhille PH, Noel LH, Reumaux D, Fleury D, Lemaitre V, Gobert P, Clin Nephrol 1990 33 257 258 2354567
34. The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies. Segelmark M, Hellmark T, Wieslander J, Nephrol Clin Pract 2003 94 59 c68 10.1159/000072022
35. European vasculitis study group: EULAR recommendations for the management of primary small and medium vessel vasculitis. Mukhtvar C, Guillevin J, Cid MC, Dasgupta B, De Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scot DG, Stegman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R, Ann Rheum Dis 2009 68 310 317 10.1136/ard.2008.088096 18413444
36. Anti-hLAMP2-antibodies and dual positivity for anti-GBM and MPO-ANCA in a patient with relapsing pulmonary-renal syndrome. Etter C, Gaspert A, Regenass S, Wuthrich R, Kistler T, Kain R, Cohen C, BMC Nephrol 2011 12 1471 2369
37. High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis. Kain R, Tadema H, McKinney EF, Benharkou A, Brandes R, Peschel A, Hubert V, Feenstra T, Sengolge G, Stegeman C, Heeringa P, Lyons PA, Smith KG, Kallenberg C, Rees AJ, J Am Soc Nephrol 2012 23 556 566 10.1681/ASN.2011090920 22323643
38. Pauci-immune focal and segmental necrotizing glomerulonephritis. KDIGO Clinical Practice Guidelines for Glomerulonephritis, Kidney Int Suppl 2012 2 233 239
39. Renal and systemic vasculitis. Jennette JC, Falk R, Comprehensive Clinical Nephrology St Louis: Elsevier, Floege J, Jonson RJ, Feehally J, 4 2010 292 307
40. Recovery of renal function in a dialysis-dependent patient with microscopic polyangiitis and both myeloperoxidase anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies. Mandai S, Nagahama K, Tsuura Y, Hirai T, Yoshioka W, Takahashi D, Aki S, Aoyagi M, Tanaka H, Tamura T, Intern Med 2011 50 1599 1603 10.2169/internalmedicine.50.4939 21804289
41. Sequential development of anti-GBM nephritis and ANCA-associated pauci-immune glomerulonephritis. Verburgh CA, Bruijn JA, Daha MR, vas Es LA, Am J Kidney Dis 1999 34 344 348 10.1016/S0272-6386(99)70366-5 10430985
42. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Salama AD, Dougan T, Levy JB, Am J Kidney Dis 2002 39 1162 1167 10.1053/ajkd.2002.33385 12046026
43. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Savige J, Davies D, Falk RJ, Jennette JC, Wiik A, Kidney Int 2000 57 846 862 10.1046/j.1523-1755.2000.057003846.x 10720938
44. Antiglomerular basement membrane disease with normal renal function